ID

30552

Description

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00821964

Link

https://clinicaltrials.gov/show/NCT00821964

Keywords

Versions (1)
  1. 6/13/18 6/13/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 13, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Male Breast Cancer NCT00821964

English

Eligibility Male Breast Cancer NCT00821964

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with advanced stage refractory breast cancer
Description

Advanced breast cancer refractory

Data type

boolean

Alias
UMLS CUI [1,1]
C3495917
UMLS CUI [1,2]
C0205269
progressive or relapsed disease following standard therapy with chemotherapy and/or surgery, and/or radiation
Description

Progressive Disease Post Standard of Care | Recurrent disease Post Standard of Care | Chemotherapy | Operative Surgical Procedures | Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1,1]
C1335499
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C2936643
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C0687676
UMLS CUI [2,3]
C2936643
UMLS CUI [3]
C0392920
UMLS CUI [4]
C0543467
UMLS CUI [5]
C1522449
patients must have measurable (bi-dimensional) chest wall disease and/or cutaneous metastatic lesions
Description

Measurable Disease 2-Dimensional Chest wall | Metastatic Lesion Cutaneous

Data type

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1705052
UMLS CUI [1,3]
C0205076
UMLS CUI [2,1]
C1513183
UMLS CUI [2,2]
C0221912
patients must be at least 7 days from last chemotherapy and 30 days from local radiotherapy and/or systemic steroids
Description

Chemotherapy Discontinued | Therapeutic radiology procedure Local Discontinued | Systemic steroids Discontinued

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1444662
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0205276
UMLS CUI [2,3]
C1444662
UMLS CUI [3,1]
C2825233
UMLS CUI [3,2]
C1444662
patients on bisphosphonates, trastuzumab, lapatinib and/or hormonal therapy are eligible
Description

Diphosphonates | Trastuzumab | Lapatinib | Hormone Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C0728747
UMLS CUI [3]
C1506770
UMLS CUI [4]
C0279025
white blood cell count >= 1000/ul
Description

White Blood Cell Count procedure

Data type

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count (anc) >= 1200/ul
Description

Absolute neutrophil count

Data type

boolean

Alias
UMLS CUI [1]
C0948762
platelets > 75,000/ul
Description

Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0032181
serum creatinine =< 2.0 mg/dl, a creatinine clearance > 60 ml/min
Description

Creatinine measurement, serum | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
alanine aminotransferase (alt) and aspartate aminotransferase (ast) < 2 x upper limit normal (uln)
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
total bilirubin < 2 x uln
Description

Serum total bilirubin measurement

Data type

boolean

Alias
UMLS CUI [1]
C1278039
patients must have a performance status score (eastern cooperative oncology group [ecog] scale) =< 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
patients must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment
Description

Communicable Disease Major | Major surgery | Patient recovered | Absence Comorbidity Preventing Investigational Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0679637
UMLS CUI [3]
C1115804
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0009488
UMLS CUI [4,3]
C1292733
UMLS CUI [4,4]
C0949266
men and women of reproductive ability must agree to contraceptive use during the study and for 1 month after imiquimod/abraxane treatment is discontinued
Description

Females & males of reproductive potential Contraceptive methods | Imiquimod Discontinued | Abraxane Discontinued

Data type

boolean

Alias
UMLS CUI [1,1]
C4034483
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0165032
UMLS CUI [2,2]
C1444662
UMLS CUI [3,1]
C1564985
UMLS CUI [3,2]
C1444662
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with prior allergic reaction to taxanes
Description

Allergic Reaction Taxanes

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0796419
patients with any clinically significant active autoimmune disease requiring active treatment with systemic steroids or other immunomodulators
Description

Autoimmune Disease Requirement Systemic steroids | Autoimmune Disease Requirement Immunomodulators

Data type

boolean

Alias
UMLS CUI [1,1]
C0004364
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C2825233
UMLS CUI [2,1]
C0004364
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C1527392
pregnant or breast-feeding women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients with peripheral neuropathy >= grade 2
Description

Peripheral Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
Back to the top of the page

Similar models

Eligibility Male Breast Cancer NCT00821964

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Advanced breast cancer refractory
Item
patients with advanced stage refractory breast cancer
boolean
C3495917 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
Progressive Disease Post Standard of Care | Recurrent disease Post Standard of Care | Chemotherapy | Operative Surgical Procedures | Therapeutic radiology procedure
Item
progressive or relapsed disease following standard therapy with chemotherapy and/or surgery, and/or radiation
boolean
C1335499 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C2936643 (UMLS CUI [1,3])
C0277556 (UMLS CUI [2,1])
C0687676 (UMLS CUI [2,2])
C2936643 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3])
C0543467 (UMLS CUI [4])
C1522449 (UMLS CUI [5])
Measurable Disease 2-Dimensional Chest wall | Metastatic Lesion Cutaneous
Item
patients must have measurable (bi-dimensional) chest wall disease and/or cutaneous metastatic lesions
boolean
C1513041 (UMLS CUI [1,1])
C1705052 (UMLS CUI [1,2])
C0205076 (UMLS CUI [1,3])
C1513183 (UMLS CUI [2,1])
C0221912 (UMLS CUI [2,2])
Chemotherapy Discontinued | Therapeutic radiology procedure Local Discontinued | Systemic steroids Discontinued
Item
patients must be at least 7 days from last chemotherapy and 30 days from local radiotherapy and/or systemic steroids
boolean
C0392920 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0205276 (UMLS CUI [2,2])
C1444662 (UMLS CUI [2,3])
C2825233 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Diphosphonates | Trastuzumab | Lapatinib | Hormone Therapy
Item
patients on bisphosphonates, trastuzumab, lapatinib and/or hormonal therapy are eligible
boolean
C0012544 (UMLS CUI [1])
C0728747 (UMLS CUI [2])
C1506770 (UMLS CUI [3])
C0279025 (UMLS CUI [4])
White Blood Cell Count procedure
Item
white blood cell count >= 1000/ul
boolean
C0023508 (UMLS CUI [1])
Absolute neutrophil count
Item
absolute neutrophil count (anc) >= 1200/ul
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelets > 75,000/ul
boolean
C0032181 (UMLS CUI [1])
Creatinine measurement, serum | Creatinine clearance measurement
Item
serum creatinine =< 2.0 mg/dl, a creatinine clearance > 60 ml/min
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
alanine aminotransferase (alt) and aspartate aminotransferase (ast) < 2 x upper limit normal (uln)
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Serum total bilirubin measurement
Item
total bilirubin < 2 x uln
boolean
C1278039 (UMLS CUI [1])
ECOG performance status
Item
patients must have a performance status score (eastern cooperative oncology group [ecog] scale) =< 2
boolean
C1520224 (UMLS CUI [1])
Communicable Disease Major | Major surgery | Patient recovered | Absence Comorbidity Preventing Investigational Therapy
Item
patients must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment
boolean
C0009450 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0679637 (UMLS CUI [2])
C1115804 (UMLS CUI [3])
C0332197 (UMLS CUI [4,1])
C0009488 (UMLS CUI [4,2])
C1292733 (UMLS CUI [4,3])
C0949266 (UMLS CUI [4,4])
Females & males of reproductive potential Contraceptive methods | Imiquimod Discontinued | Abraxane Discontinued
Item
men and women of reproductive ability must agree to contraceptive use during the study and for 1 month after imiquimod/abraxane treatment is discontinued
boolean
C4034483 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0165032 (UMLS CUI [2,1])
C1444662 (UMLS CUI [2,2])
C1564985 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Allergic Reaction Taxanes
Item
patients with prior allergic reaction to taxanes
boolean
C1527304 (UMLS CUI [1,1])
C0796419 (UMLS CUI [1,2])
Autoimmune Disease Requirement Systemic steroids | Autoimmune Disease Requirement Immunomodulators
Item
patients with any clinically significant active autoimmune disease requiring active treatment with systemic steroids or other immunomodulators
boolean
C0004364 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C2825233 (UMLS CUI [1,3])
C0004364 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C1527392 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Peripheral Neuropathy CTCAE Grades
Item
patients with peripheral neuropathy >= grade 2
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial